American Society of Hematology

Figure 1.

Summary of updated response rates and MRD-negativity rates (10‒5or 10−6threshold) over time for D-RVd in the safety run-in cohort (N = 16) of GRIFFIN. (A) Response rates over time are shown for the response-evaluable population (n = 16). (B) MRD-negativity rates over time are shown for the intent-to-treat population (N = 16). CR, complete response; ORR, overall response rate; PR, partial response; VGPR, very good partial response. *Percentages do not add up to 100% because of rounding.

Summary of updated response rates and MRD-negativity rates (10^‒5or 10⁻⁶threshold) over time for D-RVd in the safety run-in cohort (N = 16) of GRIFFIN. (A) Response rates over time are shown for the response-evaluable population (n = 16). (B) MRD-negativity rates over time are shown for the intent-to-treat population (N = 16). CR, complete response; ORR, overall response rate; PR, partial response; VGPR, very good partial response. *Percentages do not add up to 100% because of rounding.

This Feature Is Available To Subscribers Only